PetMed Express Files 8-K on Financials and Listing Status

Ticker: PETS · Form: 8-K · Filed: 2025-11-13T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, listing-rule, exhibits

Related Tickers: PETS

TL;DR

PETS filed an 8-K detailing financial results and potential listing issues.

AI Summary

PetMed Express, Inc. filed an 8-K on November 13, 2025, reporting on its results of operations and financial condition. The filing also addresses a notice of delisting or failure to satisfy a continued listing rule and includes financial statements and exhibits. The report covers events as of November 12, 2025.

Why It Matters

This filing provides crucial updates on PetMed Express's financial health and its compliance with stock exchange listing requirements, which could impact investor confidence and stock valuation.

Risk Assessment

Risk Level: medium — The filing mentions a notice of delisting or failure to satisfy a continued listing rule, which indicates potential significant risks for the company.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.

What is the nature of the 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'?

The filing states this notice was issued but does not detail the specific rule or standard that was not met.

When did the events reported in this filing occur?

The earliest event reported occurred on November 12, 2025.

What is the primary business of PetMed Express, Inc.?

PetMed Express, Inc. is identified under the Standard Industrial Classification as 'RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]'.

Where are PetMed Express, Inc.'s principal executive offices located?

The principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

From the Filing

0001040130-25-000086.txt : 20251113 0001040130-25-000086.hdr.sgml : 20251113 20251113083159 ACCESSION NUMBER: 0001040130-25-000086 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20251112 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251113 DATE AS OF CHANGE: 20251113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251475603 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20251112.htm 8-K pets-20251112 0001040130 FALSE 0001040130 2025-11-12 2025-11-12 0001040130 us-gaap:CommonStockMember 2025-11-12 2025-11-12 0001040130 us-gaap:PreferredStockMember 2025-11-12 2025-11-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 2.02 Results of Operations and Financial Condition. On November 13, 2025, PetMed Express, Inc. (the “Company”) issued a press release announcing preliminary estimated revenues for the three- and nine-month periods ended September 30, 2025. These preliminary estimated revenues are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company’s financial condition as of September 30, 2025, or its results of operations for the three- and nine-month periods ended September 30, 2025. A co

View on Read The Filing